Keyphrases
Chemotherapy
100%
Protein Biomarkers
100%
Circulating Proteins
100%
Metastatic Pancreatic Ductal Adenocarcinoma
100%
Interleukin-6
80%
Overall Survival
80%
TNFRSF12A
80%
CXCL13
40%
Programmed Death-ligand 1 (PD-L1)
40%
CSF-1
40%
Protein Level
20%
Interleukin-10
20%
Treatment Group
20%
Longitudinal Samples
20%
Serum Samples
20%
Early Change
20%
Protein Signature
20%
Protein Index
20%
Dismal Prognosis
20%
Carbohydrate Antigen 19-9 (CA19-9)
20%
Lasso Regression
20%
Protein Panel
20%
Immuno-oncology
20%
O-linked
20%
Ridge Regression Model
20%
Bioinformatician
20%
Prognostic Signature
20%
ANGPT2
20%
Medicine and Dentistry
Biological Marker
100%
Pancreas Adenocarcinoma
100%
Interleukin-6
80%
Overall Survival
80%
Group Therapy
20%
Oncology
20%
Immunoglobulin
20%
CA19-9
20%
Bioinformatician
20%
Prognostic Signature
20%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Chemotherapy
100%
Pancreas Adenocarcinoma
100%
Overall Survival
80%
Immunoglobulin
20%
Biochemistry, Genetics and Molecular Biology
Interleukin-6
100%
Overall Survival
100%
CXCL13
50%
Intravenous Immunoglobulin
25%
CA19-9
25%
TRAIL
25%
ANGPT2
25%
Neuroscience
CXCL13
100%
Intravenous Immunoglobulin
50%